Table 2.
Fat distribution in recently-diagnosed type 2 diabetes patients and individuals with normal glucose tolerance
| Variable | CON | T2D | P |
|---|---|---|---|
| Waist circumference, cm | 104 [97; 112] | 107 [100; 113] | 0.475 |
| Body fat, % | 27 [21; 37] | 26 [23; 36] | 0.504 |
| Lean body weight, kg | 68 [53; 80] | 73 [59; 78] | 0.812 |
| SSAT thickness, cm | 1.1 [0.9; 1.4] | 0.8 [0.6; 1.0] | <0.05 |
| DSAT thickness, cm | 1.3 [1.2; 1.8] | 1.9 [1.7; 2.5] | <0.05 |
| WSAT thickness, cm | 2.4 [2.1; 3.2] | 2.7 [2.4; 3.5] | 0.427 |
| WSAT volume, cm3§ | 25 569 [16 581; 30 777] | 21 344 [16 804; 28 373] | 0.586 |
| VAT volume, cm3§ | 4055 [2481; 4386] | 5417 [4513; 5851] | <0.05 |
| WSAT & VAT volume, cm3§ | 54 769 [31 877; 65 621] | 47 268 [37 845; 61 900] | 0.894 |
| HCL, % of water signal | 2.5 [1.0; 8.1] | 9.2 [5.2; 20.0] | <0.05 |
Data are shown as median [first; third quartile], P values were computed via 2-tailed Mann-Whitney U test. Body fat and lean body weight was assessed by bioimpedance analysis. The abdominal adipose tissue tickness was assessed by ultrasound and the adipose tissue volume by magnetic-resonance-imaging. Abbreviations: CON, controls (individuals with normal glucose tolerance); DSAT, deep subcutaneous adipose tissue; HCL, hepatocellular lipid content; SSAT, superficial subcutaneous adipose tissue; T2D, type 2 diabetes; VAT, visceral adipose tissue; WSAT, whole subcutaneous adipose tissue.
§Two participants per group had no analyses of fat volume, because the measurements were not usable due to metallic implants. All other variables were assessed in n = 14 T2D and n = 14 CON participants.